We are delighted to announce the establishment of a new subsidiary business, Scitech GmbH, in Germany. This strategic move is part of Scitech’s growth and succession strategy, aimed at expanding our service offering and capitalising on new opportunities.
An integral part of the Scitech family, Scitech GmbH will provide quality and regulatory consulting, qualification and validation services, design and engineering, and other consultancy support within the traditional pharmaceutical environment, primarily in German-speaking Europe. Additionally, Scitech GmbH will operate as a global centre of excellence in radiopharmaceuticals, supplementing and drawing on the extensive proficiency of subject matter experts from across the Scitech group.
By consolidating and developing Scitech’s global radiopharmaceutical proposition, we will enhance our strong reputation and capabilities in the sector. Scitech GmbH will leverage Scitech’s portfolio, relationships and ongoing projects, particularly in North America and Europe, to create a compelling global radiopharmaceutical proposition.
“Our expansion into Germany with the establishment of Scitech GmbH marks a significant milestone in our growth strategy,” said Dave Grant, Scitech Engineering Ltd. Managing Director. “We are delighted to strengthen our presence in Europe and seize the growing opportunities globally in the radiopharmaceutical sector. This move aligns with our vision to provide exceptional technical, quality and regulatory consulting services while further solidifying our position as a global leader.”
The office of Scitech GmbH will be located in Braunschweig (Brunswick), Lower Saxony, Germany. The subsidiary’s service offering will complement the existing delivery capabilities of Scitech’s UK and Antwerp offices. Antwerp, in particular, will continue to play a vital role in engineering, quality, and regulatory consulting across Europe, while the UK offices will remain integral to Scitech’s global radiopharmaceutical project delivery.
Marlous van der Hooft, has been appointed as Managing Director and General Manager of Scitech GmbH and will spearhead the expansion within Germany and Europe’s German-speaking markets.
With a background in pharmaceutical microbiology, Marlous’s proficiency spans a wide spectrum – from lean manufacturing and process enhancement to quality control, QC method development, validation and compliance, supply chain management, regulatory strategy, and medicines licensing.
Marlous has been responsible for the project management (from design up until full operation) for 13 radiopharmaceutical manufacturing sites, led new product launches, implemented new quality systems, and led manufacturing plants. She works with her customers to deliver the best-fitting solution in order to ensure compliance, safety, and efficiency in their processes. With her skills and knowledge in GxP, ISO13485, validation and operations and quality control, it is her passion to safely and compliantly deliver at the right time against the right cost.
Marlous said: “I am delighted to lead Scitech’s expansion into Germany, a vibrant hub of scientific innovation and collaboration. This new role presents an extraordinary opportunity for Scitech to further solidify its presence on the global stage, contributing to groundbreaking advancements in radiopharmaceutical manufacturing. Together, we will unlock new possibilities, forge impactful partnerships and continue to drive excellence in delivering cutting-edge solutions to benefit patients and the healthcare community.”